COMP <GO>
JAZZ vs ASND // FREE CASH FLOW YIELD
Jazz Pharmaceuticals plc (Ireland) (NASDAQ) VS. Ascendis Pharma A/S Ordinary Share (NASDAQ) • 15-METRIC TALLY: JAZZ 2
— ASND 9
▲ FREE CASH FLOW YIELD LEADER: JAZZ
LAST: $214.44 (-0.71%) • MKT CAP: $14.02B
fcf-yield
9.61%
LAST: $248.98 (-0.91%) • MKT CAP: $16.55B
fcf-yield
2.21%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JAZZ VS. ASND)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JAZZ | ASND | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.70% | 9.90% | -14.60 | ASND | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 21.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 9.61% | 2.21% | +7.40 | JAZZ | /fcf-yield <GO> |
| Operating Margin | -10.10% | 13.90% | -24.00 | ASND | /operating-margins <GO> |
| Net Profit Margin | -8.30% | 10.90% | -19.20 | ASND | /net-margins <GO> |
| Revenue Growth (YoY) | 4.90% | 12.10% | -7.20 | ASND | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.97 | 3.74 | -1.77 | ASND | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | ASND | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.5 | 63.3 | -14.80 | ASND | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 0.98 | +0.11 | JAZZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 27.6x | +8.40 | ASND | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.02B | $16.55B | -$2.53B | ASND | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JAZZ REV | ASND REV | JAZZ GROSS % | ASND GROSS % | JAZZ FCF | ASND FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.27B | — | — | — | $1.30B | — |
| FY 2024 | $4.07B | — | — | — | $1.36B | — |
| FY 2023 | $3.83B | — | — | — | $919.5M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JAZZ // BETA 1.09
ASND // BETA 0.98